Tango Therapeutics, Inc.

NasdaqGM:TNGX Stock Report

Market Cap: US$2.4b

Tango Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TNGX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Feb 26SellUS$18,844,966Third Rock Ventures, LLCCompany1,500,000US$12.59
03 Feb 26SellUS$226,300Adam CrystalIndividual18,452US$12.90
03 Feb 26SellUS$374,294Barbara WeberIndividual30,519US$12.90
03 Feb 26SellUS$126,531Daniella BeckmanIndividual10,317US$12.90
19 Nov 25SellUS$12,354,149Third Rock Ventures, LLCCompany1,500,000US$8.27
12 Nov 25SellUS$32,542,609Third Rock Ventures, LLCCompany4,012,000US$8.20
23 Oct 25SellUS$4,846,575Third Rock Ventures, LLCCompany477,401US$10.15
25 Sep 25SellUS$4,008,500Third Rock Ventures, LLCCompany500,000US$8.02
16 Sep 25SellUS$2,559,329Third Rock Ventures, LLCCompany363,541US$7.04
08 Sep 25SellUS$5,108,970Third Rock Ventures, LLCCompany729,365US$7.04
22 Aug 25SellUS$2,115,358Third Rock Ventures, LLCCompany302,194US$7.00
19 Aug 25SellUS$7,712,760Third Rock Ventures, LLCCompany1,100,000US$7.01

Insider Trading Volume

Insider Buying: TNGX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TNGX?
Owner TypeNumber of SharesOwnership Percentage
Public Companies00%
Private Companies326,8860.189%
Individual Insiders1,727,6180.999%
VC/PE Firms28,193,54916.3%
Hedge Funds44,617,77925.8%
Institutions98,153,13356.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 32%.

Top Shareholders

Top 25 shareholders own 102.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.15%
Farallon Capital Management, L.L.C.
13,061,411US$224.0m21.4%1.29%
8.94%
TCG Crossover Management, LLC
12,762,094US$218.9m49.5%6.11%
7.62%
Boxer Capital Management, LLC
10,876,219US$186.5m11.3%32.23%
7.43%
Adage Capital Management, L.P.
10,607,924US$181.9m322%0.26%
7.06%
Woodline Partners LP
10,072,225US$172.7m67%0.64%
5.99%
BlackRock, Inc.
8,540,797US$146.5m51.3%no data
5.72%
Artal Group S.A.
8,165,374US$140.0m38.8%2.67%
5.09%
Nextech Invest Ltd.
7,266,081US$124.6m31.3%8.79%
4.73%
The Vanguard Group, Inc.
6,750,977US$115.8m33.6%no data
4.47%
Third Rock Ventures, LLC
6,374,574US$109.3m-21%11.5%
4.36%
State Street Global Advisors, Inc.
6,218,567US$106.6m84.8%no data
3.7%
Balyasny Asset Management L.P.
5,278,580US$90.5m52%0.18%
3.38%
The Goldman Sachs Group, Inc.
4,819,724US$82.7m236%0.03%
2.94%
Logos Global Management, L.P.
4,200,000US$72.0m342%4.16%
2.75%
Bellevue Asset Management AG
3,927,670US$67.4m0%0.87%
2.61%
Caligan Partners, LP
3,729,895US$64.0m0%5.18%
2.5%
Nantahala Capital Management, LLC
3,572,633US$61.3m97.4%3.46%
2.04%
Deerfield Management Company, L.P.
2,906,946US$49.9m0%0.63%
2.01%
FMR LLC
2,867,548US$49.2m44,500%no data
1.87%
Suvretta Capital Management, LLC
2,662,227US$45.7m0%1.0%
1.85%
Janus Henderson Group plc
2,644,237US$45.3m14.9%0.02%
1.79%
Geode Capital Management, LLC
2,553,656US$43.8m35.6%no data
1.72%
Deep Track Capital, LP
2,454,562US$42.1m68.8%0.86%
1.51%
Vivo Capital, LLC
2,154,780US$37.0m177%1.98%
1.38%
Point72 Asset Management, L.P.
1,974,035US$33.9m-37.5%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/13 01:25
End of Day Share Price 2026/03/12 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tango Therapeutics, Inc. is covered by 13 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan ZhiB. Riley Securities, Inc.
Eric SchmidtCantor Fitzgerald & Co.
Hiroshi ShibutaniGoldman Sachs